Coya Therapeutics Inc. (NASDAQ: COYA)
$7.31
-0.0550 ( -0.75% ) 42.0K
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Market Data
Open
$7.31
Previous close
$7.36
Volume
42.0K
Market cap
$111.88M
Day range
$7.26 - $7.53
52 week range
$3.21 - $10.69
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Jul 15, 2024 |
| 4 | Insider transactions | 1 | Jun 05, 2024 |
| 4 | Insider transactions | 1 | Jun 05, 2024 |
| 8-k | 8K-related | 14 | Jun 05, 2024 |
| 4 | Insider transactions | 1 | Jun 05, 2024 |
| 8-k | 8K-related | 15 | May 20, 2024 |
| 8-k | 8K-related | 12 | May 09, 2024 |
| 10-q | Quarterly Reports | 51 | May 09, 2024 |
| 8-k | 8K-related | 14 | May 08, 2024 |
| ars | Annual reports | 1 | Mar 28, 2024 |